MULTICELL TECHNOLOGIES, INC.

Basic Information

MULTICELL TECHNOLOGIES, INC.
701 GEORGE WASHIGNTON HIGHWAY
LINCOLN, RI, 02865

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Engineered human lgG1 for delivery of IDDM self-epitopes

    Amount: $210,000.00

    DESCRIPTION (provided by applicant): Insulin-dependent diabetes mellitus is an autoimmune disease characterized by T cell attack of pancreatic islet cells leading to irreversible loss of the insulin ...

    SBIR Phase I 2006 Department of Health and Human Services
  2. Recombinant IalphaIp: Treatment for Sepsis

    Amount: $137,724.00

    DESCRIPTION (provided by applicant): Sepsis is the systematic and overwhelming response to infection. Once triggered, an uncontrolled cascade of coagulation, impaired fibrinolysis, and inflammation d ...

    SBIR Phase I 2005 Department of Health and Human Services
  3. Immortalized Pig Hepatocytes: A Drug Discovery Model

    Amount: $139,314.00

    DESCRIPTION (provided by applicant): Drug-drug interactions can occur in a multiple drug regimen, where one drug interferes with the metabolism of another, leading to dangerous, unpredicted, and poten ...

    SBIR Phase I 2003 Department of Health and Human Services
  4. MAMMALIAN HEPATOCYTES, A SOURCE OF THERAPEUTIC PROTEINS

    Amount: $133,586.00

    DESCRIPTION (provided by applicant): The safe and efficient production of novel therapeutic proteins represents an expanding market of the biopharmaceutical industry that is fueled by the recent compl ...

    SBIR Phase I 2002 Department of Health and Human Services
  5. N/A

    Amount: $135,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  6. N/A

    Amount: $100,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government